Clinical Trials
3 trialsNCT05126342 2025-04-06
Study to Estimate Efficacy of Combining Dostarlimab and Niraparib in Relapsed EOC After Treatment With PARPi
AGO Research GmbH
Phase 2 Withdrawn
NCT04655183 2021-06-30
Study of M4344 in Combination With Niraparib
EMD Serono
Phase 1/2 Withdrawn
NCT01244009 2016-11-07
A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)
Tesaro, Inc.
Phase 2 Withdrawn